Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 117

1.

The Estrogen-Induced miR-19 Downregulates Secretory Leucoprotease Inhibitor Expression in Monocytes.

McKiernan PJ, Smith SGJ, Durham AL, Adcock IM, McElvaney NG, Greene CM.

J Innate Immun. 2019 Jul 2:1-13. doi: 10.1159/000500419. [Epub ahead of print]

2.

Characterisation of the Major Extracellular Proteases of Stenotrophomonas maltophilia and Their Effects on Pulmonary Antiproteases.

Molloy K, Smith SG, Cagney G, Dillon ET, Greene CM, McElvaney NG.

Pathogens. 2019 Jun 28;8(3). pii: E92. doi: 10.3390/pathogens8030092.

3.

From the pathophysiology of the human lung alveolus to epigenetic editing: Congress 2018 highlights from ERS Assembly 3 "Basic and Translational Science."

Nikolić MZ, Garrido-Martin EM, Greiffo FR, Fabre A, Heijink IH, Boots A, Greene CM, Hiemstra PS, Bartel S.

ERJ Open Res. 2019 May 10;5(2). pii: 00194-2018. doi: 10.1183/23120541.00194-2018. eCollection 2019 Apr. Review.

4.

Nebulised lipid-polymer hybrid nanoparticles for the delivery of a therapeutic anti-inflammatory microRNA to bronchial epithelial cells.

Vencken S, Foged C, Ramsey JM, Sweeney L, Cryan SA, MacLoughlin RJ, Greene CM.

ERJ Open Res. 2019 Apr 8;5(2). pii: 00161-2018. doi: 10.1183/23120541.00161-2018. eCollection 2019 Apr.

5.

Systematic evaluation of the microRNAome through miR-CATCHv2.0 identifies positive and negative regulators of BRAF-X1 mRNA.

Marranci A, D'Aurizio R, Vencken S, Mero S, Guzzolino E, Rizzo M, Pitto L, Pellegrini M, Chiorino G, Greene CM, Poliseno L.

RNA Biol. 2019 Jul;16(7):865-878. doi: 10.1080/15476286.2019.1600934. Epub 2019 Apr 19.

PMID:
30929607
6.

Unmasking the pathological and therapeutic potential of histone deacetylases for liver cancer.

Zhao J, Gray SG, Greene CM, Lawless MW.

Expert Rev Gastroenterol Hepatol. 2019 Mar;13(3):247-256. doi: 10.1080/17474124.2019.1568870. Epub 2019 Jan 29. Review.

PMID:
30791763
7.

Knockdown of Gene Expression in Macrophages by microRNA Mimic-Containing Poly (Lactic-co-glycolic Acid) Microparticles.

McKiernan PJ, Lynch P, Ramsey JM, Cryan SA, Greene CM.

Medicines (Basel). 2018 Dec 15;5(4). pii: E133. doi: 10.3390/medicines5040133.

8.

Author Correction: α1-Antitrypsin deficiency.

Greene CM, Marciniak SJ, Teckman J, Ferrarotti I, Brantly ML, Lomas DA, Stoller JK, McElvaney NG.

Nat Rev Dis Primers. 2018 Oct 29;4(1):40. doi: 10.1038/s41572-018-0043-2.

PMID:
30374103
9.

New players in chronic lung disease identified at the European Respiratory Society International Congress in Paris 2018: from microRNAs to extracellular vesicles.

Burgy O, Fernandez Fernandez E, Rolandsson Enes S, Königshoff M, Greene CM, Bartel S.

J Thorac Dis. 2018 Sep;10(Suppl 25):S2983-S2987. doi: 10.21037/jtd.2018.08.20. No abstract available.

10.

The therapeutic properties of resminostat for hepatocellular carcinoma.

Zhao J, Gray SG, Wabitsch M, Greene CM, Lawless MW.

Oncoscience. 2018 Jun 23;5(5-6):196-208. doi: 10.18632/oncoscience.420. eCollection 2018 May.

11.

Airway Epithelium Dysfunction in Cystic Fibrosis and COPD.

De Rose V, Molloy K, Gohy S, Pilette C, Greene CM.

Mediators Inflamm. 2018 Apr 8;2018:1309746. doi: 10.1155/2018/1309746. eCollection 2018. Review.

12.

Gender disparities in preterm neonatal outcomes.

O'Driscoll DN, McGovern M, Greene CM, Molloy EJ.

Acta Paediatr. 2018 May 11. doi: 10.1111/apa.14390. [Epub ahead of print] Review.

PMID:
29750838
13.

CFTR dysfunction in cystic fibrosis and chronic obstructive pulmonary disease.

Fernandez Fernandez E, De Santi C, De Rose V, Greene CM.

Expert Rev Respir Med. 2018 Jun;12(6):483-492. doi: 10.1080/17476348.2018.1475235. Epub 2018 May 23. Review.

14.

Non-coding RNA in cystic fibrosis.

Glasgow AMA, De Santi C, Greene CM.

Biochem Soc Trans. 2018 Jun 19;46(3):619-630. doi: 10.1042/BST20170469. Epub 2018 May 9. Review.

PMID:
29743276
15.

Challenges and future direction of molecular research in air pollution-related lung cancers.

Shahadin MS, Ab Mutalib NS, Latif MT, Greene CM, Hassan T.

Lung Cancer. 2018 Apr;118:69-75. doi: 10.1016/j.lungcan.2018.01.016. Epub 2018 Jan 31. Review.

PMID:
29572006
16.

Assembly 3: Basic and Translational Sciences.

Greene CM, Hiemstra PS.

Breathe (Sheff). 2018 Mar;14(1):67-68. doi: 10.1183/20734735.020017.

17.

Cystic fibrosis epithelial cells are primed for apoptosis as a result of increased Fas (CD95).

Chen Q, Pandi SPS, Kerrigan L, McElvaney NG, Greene CM, Elborn JS, Taggart CC, Weldon S.

J Cyst Fibros. 2018 Sep;17(5):616-623. doi: 10.1016/j.jcf.2018.01.010. Epub 2018 Mar 2.

PMID:
29486923
18.

Identification of a novel functional miR-143-5p recognition element in the Cystic Fibrosis Transmembrane Conductance Regulator 3'UTR.

De Santi C, Gadi S, Swiatecka-Urban A, Greene CM.

AIMS Genet. 2018 Feb 23;5(1):53-62. doi: 10.3934/genet.2018.1.53. eCollection 2018.

19.

Innate Immunity of the Lung: From Basic Mechanisms to Translational Medicine.

Hartl D, Tirouvanziam R, Laval J, Greene CM, Habiel D, Sharma L, Yildirim AÖ, Dela Cruz CS, Hogaboam CM.

J Innate Immun. 2018;10(5-6):487-501. doi: 10.1159/000487057. Epub 2018 Feb 13.

20.

Biopolymer-Based Nanoparticles for Cystic Fibrosis Lung Gene Therapy Studies.

Fernández Fernández E, Santos-Carballal B, de Santi C, Ramsey JM, MacLoughlin R, Cryan SA, Greene CM.

Materials (Basel). 2018 Jan 13;11(1). pii: E122. doi: 10.3390/ma11010122.

Supplemental Content

Loading ...
Support Center